Minimalnie inwazyjna chirurgia jaskry (MIGS): implant XEN

• Authors: Dorota Pożarowska , Tomasz Żarnowski

Title variants

EN

Minimally invasive glaucoma surgery (MIGS): XEN implant

• Languages of publication: PL

Abstracts

PL

Pomimo nieustannego rozwoju medycyny jedyną możliwością leczenia jaskry jest obniżanie ciśnienia wewnątrzgałkowego. Spośród dostępnych możliwości terapeutycznych chirurgia filtracyjna charakteryzuje się wysoką skutecznością stosowanych procedur, ale też niskim profilem bezpieczeństwa. Zastosowanie coraz bardziej popularnych technik minimalnie inwazyjnych stwarza nadzieję na uzyskanie ciśnienia docelowego przy mniejszej liczbie powikłań. Implant XEN® jest stentem, który naśladując zasadę trabekulektomii, tj. wytwarzając filtrację podspojówkową, pozwala osiągnąć skuteczną redukcję ciśnienia wewnątrzgałkowego przy zachowaniu wysokiego profilu bezpieczeństwa.

EN

Despite all the advances in medicine, still the only proven way of glaucoma treatment is lowering intraocular pressure. Among therapeutic options, filtration surgery is one of the most effective procedures, but its safety profile is quite low. Today, minimally invasive techniques give hope that achieving the target intraocular pressure with less surgical complications is possible. XEN® implant proves to be effective in lowering intraocular pressure with high safety profile of the implantation procedure.

Keywords

EN

implant XEN; jaskra; minimalnie inwazyjna chirurgia jaskry

Discipline

• MEDICINE: MEDICINE

• Publisher: Medical Education
• Journal: OphthaTherapy
• Year: 2019
• Volume: 6
• Issue: 1
• Pages: 18-23

Contributors

author

Dorota Pożarowska

• Klinika Diagnostyki i Mikrochirurgii Jaskry, Uniwersytet Medyczny w Lublinie

author

Tomasz Żarnowski

• Klinika Diagnostyki i Mikrochirurgii Jaskry, Uniwersytet Medyczny w Lublinie

References

• 1. Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121(11): 2081-2090.
• 2. Europejskie Towarzystwo Jaskrowe. Zasady i metody leczenia. Terminologia i wytyczne postępowania w jaskrze. Wyd. IV. EGS 2016.
• 3. Heijl A, Leske MC, Bengtsson B, et al.; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120(10): 1268-1279.
• 4. Gedde SJ, Schiffman JC, Feuer WJ, et al.; Tube versus Trabeculectomy Study Group. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 2012; 153(5): 789-803.e2.
• 5. Chaudhary A, Salinas L, Guidotti J, et al. XEN Gel Implant: a new surgical approach in glaucoma. Expert Rev Med Devices 2018; 15(1): 47-59.
• 6. Gedde SJ, Herndon LW, Brandt JD, et al.; Tube Versus Trabeculectomy Study Group. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 2012; 153(5): 804-814.e1.
• 7. Kerr NM, Wang J, Barton K. Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma. Clin Exp Ophthalmol 2017; 45(4): 393-400.
• 8. Pillunat LE, Erb C, Jünemann AG, et al. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clin Ophthalmol 2017; 11: 1583-1600.
• 9. Lavia C, Dallorto L, Maule M, et al. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. PLoS One 2017; 12(8): e0183142.
• 10. Chatzara A, Chronopoulou I, Theodossiadis G, et al. XEN Implant for Glaucoma Treatment: A Review of the Literature. Semin Ophthalmol 2019; 34(2): 93-97.
• 11. Midha N, Rao HL, Mermoud A, et al. Identifying the predictors of needling after XEN gel implant. Eye (Lond) 2019; 33(3): 353-357.
• 12. Yadav KS, Sharma S. Implantable drainage devices in glaucoma: Quo vadis? Eur J Pharm Sci 2019; 133: 1-7.
• 13. Lenzhofer M, Strohmaier C, Hohensinn M, et al. Longitudinal bleb morphology in anterior segment OCT after minimally invasive transscleral ab interno Glaucoma Gel Microstent implantation. Acta Ophthalmol 2019; 97(2): e231-e237.
• 14. Ibáñez-Muñoz A, Soto-Biforcos VS, Chacón-González M, et al. One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients. Eur J Ophthalmol 2018: 1120672118795063.
• 15. Mansouri K, Gillmann K, Rao HL, et al. Prospective Evaluation of XEN Gel Implant in Eyes With Pseudoexfoliative Glaucoma. J Glaucoma 2018; 27(10): 869-873.
• 16. Karimi A, Hopes M, Martin KR, et al. Efficacy and Safety of the Ab-interno Xen Gel Stent After Failed Trabeculectomy. J Glaucoma 2018; 27(10): 864-868.
• 17. Tailor R, Lalias T. A Case of Refractory Neovascular Glaucoma Treated With a XEN 45 Implant. J Glaucoma 2018; 27(10): 929-930.
• 18. Marques RE, Ferreira NP, Sousa DC, et al. Glaucoma Gel Implant Learning Curve in a Teaching Tertiary Hospital. J Glaucoma 2019; 28(1): 56-60.
• 19. Arnould L, Theillac V, Moran S, et al. Recurrent Exposure of XEN Gel Stent Implant and Conjunctival Erosion. J Glaucoma 2019; 28(3): e37-e40.
• 20. Montolío Marzo S, Lanzagorta Aresti A, Davó Cabrera JM, et al. Malignant glaucoma after XEN45 implant. Arch Soc Esp Oftalmol 2019; 94(3): 134-137.
• 21. Karimi A, Lindfield D, Turnbull A, et al. A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery. Eye (Lond) 2019; 33(3): 469-477.
• 22. Olgun A, Imamoğlu S, Karapapak M, et al. Endophthalmitis After XEN Gel Stent Implantation: 2 Cases. J Glaucoma 2018; 27(12): e191-e194.
• 23. Smith M, Charles R, Abdel-Hay A, et al. 1-year outcomes of the Xen45 glaucoma implant. Eye (Lond) 2018 [Epub ahead of print].
• 24. Mansouri K, Guidotti J, Rao HL, et al. Prospective Evaluation of Standalone XEN Gel Implant and Combined Phacoemulsification-XEN Gel Implant Surgery: 1-Year Results. J Glaucoma 2018; 27(2): 140-147.
• 25. Galal A, Bilgic A, Eltanamly R, et al. XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications. J Ophthalmol 2017; 2017: 5457246.
• 26. Reitsamer H, Sng C, Vera V, et al.; Apex Study Group. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2019 [Epub ahead of print].
• 27. De Gregorio A, Pedrotti E, Russo L, et al. Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol 2018; 38(3): 1129-1134.
• 28. Schlenker MB, Gulamhusein H, Conrad-Hengerer I, et al. Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy. Ophthalmology 2017; 124(11): 1579-1588.
• 29. Laroche D, Ng C, Lynch G. Baerveldt Attached to XEN: A New Technique to Manage Failed XEN Glaucoma Surgery. J Glaucoma 2018; 27(4): 382-384.
• 30. Ansari E. An Update on Implants for Minimally Invasive Glaucoma Surgery (MIGS). Ophthalmol Ther 2017; 6(2): 233-241.

• Document Type: article